Dare Bioscience (DARE) Institutional Ownership $2.36 +0.03 (+1.07%) As of 03:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Dare Bioscience (NASDAQ:DARE)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$245.62KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$174.43K Get DARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Dare Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data DARE Institutional Buying and Selling by Quarter Dare Bioscience Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2026 Renaissance Technologies LLC19,295$37K0.0%-67.2%0.135% 2/11/2026 LPL Financial LLC14,639$28K0.0%N/A0.102% 11/17/2025 Susquehanna International Group LLP60,221$126K0.0%-43.7%0.447% 11/14/2025 Raymond James Financial Inc.15,334$32K0.0%+810.6%0.114% 11/14/2025 Virtu Financial LLC17,740$37K0.0%N/A0.132% 10/29/2025AMH Equity Ltd232,373$488K0.6%+20.0%1.724% 8/4/2025AMH Equity Ltd193,603$463K0.6%+17.8%2.144% 5/5/2025AMH Equity Ltd164,302$475K0.7%+9.5%1.857% 2/14/2025Jane Street Group LLC16,584$52K0.0%N/A0.191% 2/13/2025Renaissance Technologies LLC68,695$214K0.0%+6.7%0.790% Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dare Bioscience and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025Geode Capital Management LLC92,653$289K0.0%+4.0%1.065% 2/5/2025AMH Equity Ltd150,000$468K0.5%+50.0%1.724% 11/16/2024Geode Capital Management LLC89,060$289K0.0%-91.2%1.042% 11/15/2024State Street Corp23,515$76K0.0%-91.7%0.275% 8/9/2024Renaissance Technologies LLC778,700$262K0.0%+2.1%9.247% 11/15/2023Armistice Capital LLC6,470,000$2.99M0.0%N/A7.370% 5/1/2023Virtu Financial LLC32,481$34K0.0%-58.1%0.038% 2/8/2023Founders Financial Securities LLC114,000$95K0.0%-67.2%0.134% 11/7/2022Virtu Financial LLC68,242$68K0.0%+29.2%0.080% 10/27/2022Founders Financial Securities LLC347,824$5.27M0.9%+236.1%0.410% 7/27/2022Founders Financial Securities LLC103,500$127K0.0%N/A0.122% 7/19/2022Commonwealth Equity Services LLC43,579$53K0.0%+57.8%0.051% 5/11/2022GSA Capital Partners LLP125,954$188K0.0%-11.2%0.150% 5/10/2022Buckingham Strategic Partners30,000$45K0.0%+200.0%0.036% 2/14/2022GSA Capital Partners LLP141,843$284K0.0%+1,077.5%0.185% 2/8/2022Raymond James Financial Services Advisors Inc.30,000$60K0.0%N/A0.039% DARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DARE shares? During the previous two years, 9 institutional investors and hedge funds held shares of Dare Bioscience. The most heavily invested institutionals were AMH Equity Ltd ($488K), Geode Capital Management LLC ($289K), Susquehanna International Group LLP ($126K), State Street Corp ($76K), Jane Street Group LLC ($52K), Renaissance Technologies LLC ($37K), and Virtu Financial LLC ($37K).Learn more on Dare Bioscience's institutional investors. What percentage of Dare Bioscience's stock is owned by institutional investors? 6.70% of Dare Bioscience's stock is owned by institutional investors. Learn more on DARE's institutional investor holdings. Which institutional investors have been buying Dare Bioscience's stock? The following institutional investors have purchased Dare Bioscience's stock in the last 24 months: AMH Equity Ltd ($132.37K), Renaissance Technologies LLC ($20.10K), Virtu Financial LLC ($17.74K), Jane Street Group LLC ($16.58K), LPL Financial LLC ($14.64K), Raymond James Financial Inc. ($13.65K), and Geode Capital Management LLC ($3.59K). How much institutional buying is happening at Dare Bioscience? Institutional investors have bought a total of 114,100 shares in the last 24 months. This purchase volume represents approximately $245.62K in transactions. Which of Dare Bioscience's major shareholders have been selling company stock? The following institutional investors have sold Dare Bioscience stock in the last 24 months: Susquehanna International Group LLP ($46.67K), and Renaissance Technologies LLC ($39.60K). How much institutional selling is happening at Dare Bioscience? Institutional investors have sold a total of 86,266 shares in the last 24 months. This volume of shares sold represents approximately $174.43K in transactions. Related Companies Cardiol Therapeutics Major Shareholders Galectin Therapeutics Major Shareholders Spero Therapeutics Major Shareholders Assertio Major Shareholders Equillium Major Shareholders Connect Biopharma Major Shareholders Rani Therapeutics Major Shareholders Journey Medical Major Shareholders Genelux Major Shareholders Aardvark Therapeutics Major Shareholders This page (NASDAQ:DARE) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
